Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
myBIOS is an Austrian biotechnology company specializing in the production of high-value recombinant proteins, industrial enzymes, and bioactive peptides. The company utilizes its proprietary methanol-free fermentation platform, based on the yeast Pichia pastoris (Komagataella phaffii), to provide sustainable and scalable protein production solutions. myBIOS serves a diverse range of industries, including pharmaceuticals, food and feed, cosmetics, and materials science. By eliminating the use of toxic methanol, their technology simplifies regulatory compliance and reduces environmental impact while maintaining high protein titers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on myBIOS.